[Pharm-policy] Ganslandt and Maskus data on Sweedish PI

[James Love]

http://spot.colorado.edu/~maskus/papers/piphv212.PDF

Parallel Imports of Pharmaceutical Products in
the European Union
Mattias Ganslandt¤
and
Keith E. Maskus



Table 2: Price changes of pharmaceuticals in Sweden 1995-1998.
                                Unweighted average Weighted average
                        Sweden 1994-1998 1997-1998 1994-1998 1997-1998

All products Mean incl. PI       0.06636 0.00253   0.00800  -0.01370
                                 (0.1344) (0.0352) (0.0276) (0.0061)

          Manuf.’s price         0.07336 0.00731   0.02791  -0.00156
                                (0.1330) (0.0308)  (0.0217) (0.0032)

PI products Mean incl. PI        0.02881 -0.03117 -0.04384  -0.03846
                                (0.1213) (0.0409) (0.0448)  (0.0086)

          Manuf.’s price         0.06381 -0.00343  0.00308  -0.00668
                                (0.1199) (0.0349)  (0.0360) (0.0052)

Non-PI prod Mean                 0.07574 0.00955   0.03646  0.00150
                                (0.1365) (0.0296)  (0.0171) (0.0035)

                    No. of obs.  125      151       125      151
Source: Author’s calculations based on data from LIF (http://www.lif.se).
Note : Std dev in parentheses. Data includes 164 di¤erent forms and dosages distributed over 50
patented molecules. The relative price changes are calculated for each unique package. The price
change for all …rms selling a unique product is a weighted average of the manufacturing …rm’s price
and the parallel importing …rm’s price.